Form 4: Black Diamond Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Prakash Raman, a Director of Black Diamond Therapeutics, Inc., received 6,801 shares of common stock on September 18, 2026.
Summary
- Grant/award: acquired 6,801 Common Stock at $1.93 ($13,126) on September 18, 2026; holds 51,840 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Prakash Raman — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-18 | Grant/award | Common Stock | 6,801 | $2 | $13.1K | 51,840 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-18 | Grant/award (6,801 shares) |
Keywords
insider transaction, Form 4, BDTX, Black Diamond Therapeutics, Inc., neutral, Prakash Raman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.